resveratrol has been researched along with Sarcopenia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Crea, E; Giacomello, E; Sirago, G; Toniolo, L | 1 |
| Asakura, S; Horio, Y; Hosoda, R; Iwahara, N; Kunimoto, R; Kuno, A; Nakashima, R; Nojima, I; Saga, Y; Yano, M | 1 |
| Chen, JL; Liao, ZY; Lv, AK; Pu, D; Sun, Y; Wang, ML; Xiao, MH; Xiao, Q; Zhao, KX; Zhao, YX; Zhou, J; Zhu, SY | 1 |
| Chen, K; Hou, P; Huang, Y; Lang, H; Mi, M; Ran, L; Yi, L; Zhang, Q; Zhang, Y; Zheng, J; Zhou, M; Zhu, X | 1 |
| Adhihetty, PJ; Carey-Love, S; Dutta, D; Joseph, AM; Leeuwenburgh, C; Malamo, AG; Nguyen, LM; Silvestre, J; Wawrzyniak, N; Xu, J | 1 |
| Alway, SE; Jackson, JR; Ryan, MJ | 1 |
6 other study(ies) available for resveratrol and Sarcopenia
| Article | Year |
|---|---|
A short-term treatment with resveratrol improves the inflammatory conditions of Middle-aged mice skeletal muscles.
Topics: Aging; Animals; Inflammation; Male; Mice; Mice, Inbred C57BL; Muscle, Skeletal; Resveratrol; Sarcopenia | 2022 |
Resveratrol, a SIRT1 activator, attenuates aging-associated alterations in skeletal muscle and heart in mice.
Topics: Aging; Animals; Hypertrophy; Mice; Muscle, Skeletal; Myocytes, Cardiac; Resveratrol; Sarcopenia; Sirtuin 1; Stilbenes | 2023 |
The effect of exercise, resveratrol or their combination on Sarcopenia in aged rats via regulation of AMPK/Sirt1 pathway.
Topics: Age Factors; Aging; AMP-Activated Protein Kinases; Animals; Apoptosis; bcl-2-Associated X Protein; Combined Modality Therapy; Disease Models, Animal; Exercise Therapy; Male; Muscle Fibers, Skeletal; Muscle Strength; Muscle, Skeletal; Physical Conditioning, Animal; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Resveratrol; Sarcopenia; Signal Transduction; Sirtuin 1; Stilbenes; Time Factors; Tumor Suppressor Protein p53 | 2017 |
Resveratrol prevents sarcopenic obesity by reversing mitochondrial dysfunction and oxidative stress via the PKA/LKB1/AMPK pathway.
Topics: Adenylate Kinase; Aging; AMP-Activated Protein Kinase Kinases; Animals; Antioxidants; Cyclic AMP-Dependent Protein Kinases; Diet, High-Fat; Male; Mitochondria; Muscle Fibers, Skeletal; Muscular Atrophy; Obesity; Oxidative Stress; Palmitic Acid; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Resveratrol; Sarcopenia; Signal Transduction | 2019 |
Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals.
Topics: Aging; AMP-Activated Protein Kinases; Animals; Apoptosis; Apoptosis Regulatory Proteins; Caloric Restriction; Combined Modality Therapy; Male; Mitochondria, Muscle; Mitochondrial Proteins; Muscle, Skeletal; Organ Size; Oxygen Consumption; Rats; Rats, Inbred F344; Resveratrol; Sarcopenia; Sirtuin 1; Stilbenes | 2013 |
Long-term supplementation with resveratrol alleviates oxidative stress but does not attenuate sarcopenia in aged mice.
Topics: Aging; Animals; Antioxidants; Dietary Supplements; Disease Models, Animal; Follow-Up Studies; Immunoblotting; Isometric Contraction; Mice; Mice, Inbred C57BL; Mitochondria, Muscle; Muscle, Skeletal; Oxidative Stress; Resveratrol; Ribonucleotide Reductases; Sarcopenia; Stilbenes; Time Factors | 2011 |